Yuki Kojima Selected Research

B cell linker protein

2/2016

B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Kojima Research Topics

Disease

13	Neoplasms (Cancer) 04/2022 - 08/2016
4	Pain (Aches) 01/2022 - 08/2016
3	Breast Neoplasms (Breast Cancer) 05/2022 - 06/2020
3	Acquired Immunodeficiency Syndrome (AIDS) 05/2018 - 04/2014
2	Lung Neoplasms (Lung Cancer) 10/2021 - 09/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2021
2	Vomiting 01/2020 - 01/2017
2	Philadelphia Chromosome 01/2019 - 08/2016
2	Leukemia 01/2019 - 02/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 02/2017 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2016 - 02/2016
2	Infections 09/2015 - 02/2014
2	Rhabdomyosarcoma 09/2012 - 07/2012
1	Pleural Effusion (Pleural Effusions) 02/2022
1	Synovial Sarcoma (Synovioma) 01/2022
1	Postoperative Pain 01/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2021
1	Cushing Syndrome 12/2021
1	Adrenocortical Carcinoma 12/2021
1	Ovarian Neoplasms (Ovarian Cancer) 12/2020
1	Carcinoma (Carcinomatosis) 12/2020
1	Adenosquamous Carcinoma 10/2020
1	Adenocarcinoma 10/2020
1	Triple Negative Breast Neoplasms 06/2020
1	Emergence Delirium 01/2020
1	Delirium 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Blindness (Hysterical Blindness) 01/2020
1	Postoperative Nausea and Vomiting (PONV) 01/2020
1	Carcinosarcoma 10/2019
1	Genetic Translocation (Chromosomal Translocation) 01/2019
1	Chronic Renal Insufficiency 06/2018
1	Hyperkalemia 06/2018

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2012
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2020
2	eribulin FDA Link 01/2022 - 06/2020
2	Tyrosine Kinase InhibitorsIBA 10/2021 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 09/2015
2	Pharmaceutical PreparationsIBA 02/2017 - 08/2016
2	Vincristine (Oncovin)FDA LinkGeneric 09/2012 - 07/2012
2	Dactinomycin (Actinomycin)FDA LinkGeneric 09/2012 - 07/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2012 - 07/2012
1	Peptides (Polypeptides)IBA 04/2022
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 04/2022
1	big gastrinIBA 04/2022
1	squamous cell carcinoma-related antigenIBA 04/2022
1	Keratins (Keratin)IBA 04/2022
1	Fetal Proteins (Fetoprotein)IBA 04/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2022
1	AntigensIBA 04/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 04/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 04/2022
1	Sialyl Lewis X AntigenIBA 04/2022
1	Carcinoembryonic AntigenIBA 04/2022
1	CarbohydratesIBA 04/2022
1	Vitamin K FDA Link 04/2022
1	Tumor Biomarkers (Tumor Markers)IBA 04/2022
1	EnzymesIBA 02/2022
1	AnthracyclinesIBA 01/2022
1	taxaneIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021
1	Etoposide (VP 16)FDA LinkGeneric 12/2021
1	Mitotane (Lysodren)FDA Link 12/2021
1	Hormones (Hormone)IBA 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Cell-Free Nucleic AcidsIBA 10/2021
1	AntibodiesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	CrizotinibIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	alectinibIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2020
1	olaparibIBA 06/2020
1	hydrogen sulfite (bisulfite)IBA 06/2020
1	Local AnestheticsIBA 01/2020
1	Anesthetics (Anesthetic Agents)IBA 01/2020
1	Ifosfamide FDA LinkGeneric 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2019
1	BradykininIBA 03/2019
1	MicroRNAs (MicroRNA)IBA 01/2019

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2022 - 07/2012
7	Therapeutics 01/2022 - 07/2012
1	Adjuvant Chemotherapy 05/2022
1	Pain Management 01/2022
1	Pulpectomy 01/2022
1	Molecular Targeted Therapy 01/2021
1	Radiotherapy 01/2021
1	Neoadjuvant Therapy 12/2020
1	Nerve Block (Nerve Blocks) 01/2020
1	General Anesthesia 01/2020
1	Conservative Treatment 06/2018